Interestingly, refractory BC patient monocytes secreted elevated amounts of CCL2, CCL4, CCL5, IL‐1α and VEGF, and lower levels of LIF when compared to sensitive patient monocytes. This evidence concerns the gene CCL5 and breast cancer.